Holders — by stockHoldings — by fund
DCF Advisers, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001802493
$444.2M
disclosed book value
94
positions
15.8%
largest position share
Positions, as of 2026-09-30
top 100 of 94 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MUMICRON TECHNOLOGY INC | 66,000 | $70.3M | 15.8% |
| 2 | QQQINVESCO QQQ TRPUT | 91,300 | $67.5M | 15.2% |
| 3 | SPYSTATE STR SPDR S&P 500 ETF TPUT | 28,000 | $21.4M | 4.8% |
| 4 | GOOGALPHABET INC | 54,000 | $18.4M | 4.1% |
| 5 | AMDADVANCED MICRO DEVICES INC | 29,000 | $17.7M | 4% |
| 6 | AMZNAMAZON COM INC | 55,000 | $13.7M | 3.1% |
| 7 | HELPCYBIN INC | 1.0M | $12.3M | 2.8% |
| 8 | ARGXARGENX SE | 11,700 | $11.2M | 2.5% |
| 9 | MUMICRON TECHNOLOGY INCCALL | 8,000 | $8.5M | 1.9% |
| 10 | TEVATEVA PHARMACEUTICAL INDS LTD | 205,500 | $8.1M | 1.8% |
| 11 | MRVLMARVELL TECHNOLOGY INC | 30,000 | $7.9M | 1.8% |
| 12 | VRTXVERTEX PHARMACEUTICALS INC | 15,150 | $7.9M | 1.8% |
| 13 | IAUISHARES GOLD TR | 100,000 | $7.8M | 1.8% |
| 14 | CRVSCORVUS PHARMACEUTICALS INC | 641,500 | $7.4M | 1.7% |
| 15 | BACBANK OF AMER CORP | 119,500 | $6.5M | 1.5% |
| 16 | ETENERGY TRANSFER L P | 300,500 | $5.9M | 1.3% |
| 17 | GDXVANECK ETF TRUST | 62,500 | $5.5M | 1.2% |
| 18 | REGNREGENERON PHARMACEUTICALS | 7,050 | $5.3M | 1.2% |
| 19 | ZMZOOM COMMUNICATIONS INC | 53,500 | $4.9M | 1.1% |
| 20 | INCYINCYTE CORP | 40,000 | $4.9M | 1.1% |
| 21 | GLDSPDR GOLD TR | 12,500 | $4.8M | 1.1% |
| 22 | CCITIGROUP INC | 36,000 | $4.7M | 1% |
| 23 | BABAALIBABA GROUP HLDG LTD | 39,700 | $4.3M | 1% |
| 24 | ORCLORACLE CORP | 29,000 | $4.0M | 0.9% |
| 25 | IVVISHARES TRPUT | 5,000 | $3.8M | 0.9% |
| 26 | IMRXIMMUNEERING CORP | 862,500 | $3.5M | 0.8% |
| 27 | BIDUBAIDU INC | 40,000 | $3.5M | 0.8% |
| 28 | SVRASAVARA INC | 670,000 | $3.5M | 0.8% |
| 29 | MSFTMICROSOFT CORP | 6,500 | $3.3M | 0.8% |
| 30 | NAMSNEWAMSTERDAM PHARMA COMPANY | 130,868 | $3.2M | 0.7% |
| 31 | LLYELI LILLY & CO | 2,700 | $3.1M | 0.7% |
| 32 | SNYSANOFI SA | 75,000 | $3.1M | 0.7% |
| 33 | UBERUBER TECHNOLOGIES INC | 45,000 | $3.1M | 0.7% |
| 34 | GDXJVANECK ETF TRUST | 25,000 | $2.8M | 0.6% |
| 35 | ABBVABBVIE INC | 10,750 | $2.8M | 0.6% |
| 36 | XAODXABRDN TOTAL DYNAMIC DIVIDEND | 266,000 | $2.7M | 0.6% |
| 37 | AVGOBROADCOM INC | 7,575 | $2.7M | 0.6% |
| 38 | XJQCXNUVEEN CR STRATEGIES INCOME | 555,613 | $2.6M | 0.6% |
| 39 | LFCRLIFECORE BIOMEDICAL INC | 376,500 | $2.5M | 0.6% |
| 40 | LRCXLAM RESEARCH CORP | 7,500 | $2.5M | 0.6% |
| 41 | BBARRICK MNG CORP | 60,000 | $2.4M | 0.5% |
| 42 | XNCRXENCOR INC | 97,736 | $2.4M | 0.5% |
| 43 | AAPLAPPLE INC | 7,250 | $2.4M | 0.5% |
| 44 | BHVNBIOHAVEN LTDCALL | 169,500 | $2.3M | 0.5% |
| 45 | AZNASTRAZENECA PLC | 14,000 | $2.3M | 0.5% |
| 46 | ZBHZIMMER BIOMET HOLDINGS INC | 24,868 | $2.2M | 0.5% |
| 47 | SLVISHARES SILVER TR | 40,000 | $2.2M | 0.5% |
| 48 | METAMETA PLATFORMS INC | 3,000 | $2.2M | 0.5% |
| 49 | BNEDBARNES & NOBLE ED INC | 184,383 | $2.1M | 0.5% |
| 50 | URNMSPROTT FDS TR | 40,000 | $1.9M | 0.4% |
| 51 | EVOEVOTEC AG | 1.0M | $1.8M | 0.4% |
| 52 | IFRXINFLARX NV | 975,000 | $1.8M | 0.4% |
| 53 | IONSIONIS PHARMACEUTICALS INC | 38,500 | $1.7M | 0.4% |
| 54 | BHVNBIOHAVEN LTD | 127,500 | $1.7M | 0.4% |
| 55 | BABOEING CO | 8,625 | $1.6M | 0.4% |
| 56 | GLDSPDR GOLD TRPUT | 4,000 | $1.5M | 0.3% |
| 57 | MDTMEDTRONIC PLC | 17,500 | $1.5M | 0.3% |
| 58 | CSCOCISCO SYS INC | 13,500 | $1.5M | 0.3% |
| 59 | ALLTALLOT LTD | 170,000 | $1.4M | 0.3% |
| 60 | GPCRSTRUCTURE THERAPEUTICS INC | 45,000 | $1.4M | 0.3% |
| 61 | AMGNAMGEN INC | 3,250 | $1.4M | 0.3% |
| 62 | KWEBKRANESHARES TRUST | 55,000 | $1.3M | 0.3% |
| 63 | PINSPINTEREST INC | 70,000 | $1.3M | 0.3% |
| 64 | QCOMQUALCOMM INC | 7,000 | $1.3M | 0.3% |
| 65 | PRTAPROTHENA CORP PLC | 129,911 | $1.1M | 0.2% |
| 66 | INTCINTEL CORP | 8,500 | $1.0M | 0.2% |
| 67 | ARQARQ INC | 510,585 | $1.0M | 0.2% |
| 68 | IBITISHARES BITCOIN TRUST ETF | 20,000 | $946,800 | 0.2% |
| 69 | QUREUNIQURE NV | 39,000 | $942,240 | 0.2% |
| 70 | ZLABZAI LAB LTD | 35,000 | $921,900 | 0.2% |
| 71 | STEWSRH TOTAL RETURN FUND INC | 50,000 | $868,500 | 0.2% |
| 72 | IWMISHARES TR | 3,000 | $833,670 | 0.2% |
| 73 | VRTXVERTEX PHARMACEUTICALS INCCALL | 1,500 | $784,215 | 0.2% |
| 74 | VRDNVIRIDIAN THERAPEUTICS INC | 38,000 | $782,420 | 0.2% |
| 75 | LYFTLYFT INC | 45,000 | $675,450 | 0.2% |
| 76 | CMPSCOMPASS PATHWAYS PLC | 54,250 | $674,870 | 0.2% |
| 77 | ZBIOZENAS BIOPHARMA INC | 23,584 | $636,060 | 0.1% |
| 78 | LNSRLENSAR INC | 94,000 | $619,460 | 0.1% |
| 79 | ANABANAPTYSBIO INC | 11,614 | $583,720 | 0.1% |
| 80 | IWMISHARES TRPUT | 2,000 | $555,780 | 0.1% |
| 81 | IBMINTERNATIONAL BUSINESS MACHS | 2,500 | $549,825 | 0.1% |
| 82 | GMABGENMAB A/S | 15,000 | $535,125 | 0.1% |
| 83 | ICUIICU MED INC | 3,225 | $517,645 | 0.1% |
| 84 | NOWSERVICENOW INC | 3,750 | $502,538 | 0.1% |
| 85 | SBUXSTARBUCKS CORP | 5,000 | $469,800 | 0.1% |
| 86 | INSMINSMED INC | 4,000 | $456,560 | 0.1% |
| 87 | TPBTURNING PT BRANDS INC | 7,500 | $440,250 | 0.1% |
| 88 | EYPTEYEPOINT INCCALL | 134,000 | $438,180 | 0.1% |
| 89 | HDHOME DEPOT INC | 1,500 | $426,735 | 0.1% |
| 90 | GMGENERAL MTRS CO | 5,300 | $408,100 | 0.1% |
| 91 | TDOCTELADOC HEALTH INC | 70,000 | $406,000 | 0.1% |
| 92 | HZOMARINEMAX INC | 7,500 | $392,250 | 0.1% |
| 93 | NNNEXTNAV INC | 26,750 | $384,665 | 0.1% |
| 94 | SPOTSPOTIFY TECHNOLOGY S A | 750 | $365,535 | 0.1% |
| 95 | OIO-I GLASS INC | 59,000 | $333,350 | 0.1% |
| 96 | ZMZOOM COMMUNICATIONS INCCALL | 3,000 | $272,310 | 0.1% |
| 97 | EIKNEIKON THERAPEUTICS INC | 33,792 | $271,688 | 0.1% |
| 98 | AMGNAMGEN INCCALL | 500 | $210,755 | 0% |
| 99 | HELPCYBIN INCCALL | 9,500 | $116,755 | 0% |
| 100 | QTTBQ32 BIO INC | 13,000 | $107,510 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.